Abstract
Patients with systemic lupus erythematosus (SLE) are at increased risk of tuberculosis (TB) infection due to immune dysfunction and immunosuppressive therapy. We present a case study of a 40-year-old woman with systemic lupus erythematosus (SLE). Initially, she was diagnosed with a lupus flare based on her clinical symptoms and laboratory results. However, upon further investigation, positive polymerase-chain reaction results for M. tuberculosis in the cerebrospinal fluid and lung parenchymal changes on chest computed tomography scan were indicative of TB infection. There was initial uncertainty regarding whether TB had triggered a flare-up of SLE or if TB was merely mimicking the symptoms of a SLE flare-up. However, as increasing the prednisolone dose did not have a positive effect and the patient’s condition improved significantly with anti-TB treatment alone, it became clearer that the deterioration observed upon admission was primarily due to TB progression rather than an SLE flare-up. Additionally, we review the current literature on TB and SLE, including risk factors, diagnostic challenges, and treatment considerations, highlighting the importance of considering TB infection in patients with SLE who present with overlap** manifestations. Prompt diagnosis and treatment are essential for improving outcomes in these patients.
Similar content being viewed by others
Data availability
All data underlying the results are available as part of the article and no additional source data are required.
References
Ameer MA, Chaudhry H, Mushtaq J, Khan OS, Babar M, Hashim T, Zeb S, Tariq MA, Patlolla SR, Ali J, Hashim SN, Hashim S (2022) An overview of systemic lupus erythematosus (SLE) pathogenesis, classification, and management. Cureus 14:e30330. https://doi.org/10.7759/cureus.30330
Harley ITW, Sawalha AH (2022) Systemic lupus erythematosus as a genetic disease. Clin Immunol 236:108953. https://doi.org/10.1016/j.clim.2022.108953
Fava A, Petri M (2019) Systemic lupus erythematosus: diagnosis and clinical management. J Autoimmun 96:1–13. https://doi.org/10.1016/j.jaut.2018.11.001
Gergianaki I, Garantziotis P, Adamichou C, Saridakis I, Spyrou G, Sidiropoulos P, Bertsias G (2021) High comorbidity burden in patients with SLE: data from the community-based lupus registry of Crete. J Clin Med 10:998. https://doi.org/10.3390/jcm10050998
Bello N, Meyers KJ, Workman J, Hartley L, McMahon M (2023) Cardiovascular events and risk in patients with systemic lupus erythematosus: systematic literature review and meta-analysis. Lupus 32:325–341. https://doi.org/10.1177/09612033221147471
Wu Q, Liu Y, Wang W, Zhang Y, Liu K, Chen SH, Chen B (2022) Incidence and prevalence of tuberculosis in systemic lupus erythematosus patients: a systematic review and meta-analysis. Front Immunol 13:938406. https://doi.org/10.3389/fimmu.2022.938406
Yu CY, Kuo CF, Chou IJ, Chen JS, Lu HY, Wu CY, Chen LC, Huang JL, Yeh KW (2022) Comorbidities of systemic lupus erythematosus prior to and following diagnosis in different age-at-onset groups. Lupus 31:963–973. https://doi.org/10.1177/09612033221100908
Torres-González P, Romero-Díaz J, Cervera-Hernández ME, Ocampo-Torres M, Chaires-Garza LG, Lastiri-González EA, Atisha-Fregoso Y, Bobadilla-Del-Valle M, Ponce-de-León A, Sifuentes-Osornio J (2018) Tuberculosis and systemic lupus erythematosus: a case-control study in Mexico City. Clin Rheumatol 37:2095–2102. https://doi.org/10.1007/s10067-018-4109-z
Cuchacovich R, Gedalia A (2009) Pathophysiology and clinical spectrum of infections in systemic lupus erythematosus. Rheum Dis Clin N Am 35:75–93. https://doi.org/10.1016/j.rdc.2009.03.003
Hamijoyo L, Sahiratmadja E, Ghassani NG, Darmawan G, Susandi E, van Crevel R, Hill PC, Alisjahbana B (2022) Tuberculosis among patients with systemic lupus erythematosus in Indonesia: a cohort study. Open Forum Infect Dis 9:ofac201. https://doi.org/10.1093/ofid/ofac201
Damara I, Ariane A, Winston K (2022) Predisposing factors of tuberculosis infection in systemic lupus erythematosus patients: a single-center case-control study. Cureus 14:e26410. https://doi.org/10.7759/cureus.26410
Mok MY, Wong SS, Chan TM, Fong DY, Wong WS, Lau CS (2007) Nontuberculous mycobacterial infection in patients with systemic lupus erythematosus. Rheumatology 46:280–284. https://doi.org/10.1093/rheumatology/kel206
Shin JI, Lee KH, Park S, Yang JW, Kim HJ, Song K, Lee S, Na H, Jang YJ, Nam JY, Kim S, Lee C, Hong C, Kim C, Kim M, Choi U, Seo J, ** H, Yi B, Jeong SJ, Sheok YO, Kim H, Lee S, Lee S, Jeong YS, Park SJ, Kim JH, Kronbichler A (2022) Systemic lupus erythematosus and lung involvement: a comprehensive review. J Clin Med 11:6714. https://doi.org/10.3390/jcm11226714
Aringer M, Costenbader KH, Daikh DI, Brinks R, Mosca M, Ramsey-Goldman R et al (2019) 2019 EULAR/ACR classification criteria for systemic lupus erythematosus. Arthritis Rheumatol 71:1400–1412. https://doi.org/10.1002/art.40930
Enocsson H, Karlsson J, Li HY, Wu Y, Kushner I, Wetterö J, Sjöwall C (2021) The complex role of C-reactive protein in systemic lupus erythematosus. J Clin Med 10:5837. https://doi.org/10.3390/jcm10245837
Liu Y, Che G, Liu Y, Xu K (2023) Tuberculosis mimicking the onset of systemic lupus erythematosus flare: case based review. Int J Rheum Dis 26:1143–1148. https://doi.org/10.1111/1756-185X.14585
Barber MRW, Drenkard C, Falasinnu T, Hoi A, Mak A, Kow NY, Svenungsson E, Peterson J, Clarke AE, Ramsey-Goldman R (2021) Global epidemiology of systemic lupus erythematosus. Nat Rev Rheumatol 17:515–532. https://doi.org/10.1038/s41584-021-00668-1
Tang G, Chen X, Han Y, Peng Q, Liu J, Liu Y, Guo H, Wu X, Liu J, Zhou Q, Long L (2023) Clinical characteristics and related influencing factors of common rheumatic diseases concomitant with tuberculosis. Front Public Health 10:948652. https://doi.org/10.3389/fpubh.2022.948652
Fanouriakis A, Kostopoulou M, Alunno A, Aringer M, Bajema I, Boletis JN, Cervera R, Doria A, Gordon C, Govoni M, Houssiau F, Jayne D, Kouloumas M, Kuhn A, Larsen JL, Lerstrøm K, Moroni G, Mosca M, Schneider M, Smolen JS, Svenungsson E, Tesar V, Tincani A, Troldborg A, van Vollenhoven R, Wenzel J, Bertsias G, Boumpas DT (2019) 2019 update of the EULAR recommendations for the management of systemic lupus erythematosus. Ann Rheum Dis 78:736–745. https://doi.org/10.1136/annrheumdis-2019-215089
Balbi GGM, Machado-Ribeiro F, Marques CDL, Signorelli F, Levy RA (2018) The interplay between tuberculosis and systemic lupus erythematosus. Curr Opin Rheumatol 30:395–402. https://doi.org/10.1097/BOR.0000000000000493
Fang H, Lan L, Qu Y, Zhang Q, Lv J (2018) Differences between central nervous system infection and neuropsychiatric systemic lupus erythematosus in patients with systemic lupus erythematosus. J Int Med Res 46:485–491. https://doi.org/10.1177/0300060517722695
Miras MDMA, Hidalgo-Tenorio C, Jimenez-Gamiz P, Jimenez-Alonso J (2014) Diagnosis of latent tuberculosis in patients with systemic lupus erythematosus: T.SPOT.TB versus tuberculin skin test. Biomed Res Int 2014:291031. https://doi.org/10.1155/2014/291031
Kadavath S, Zapantis E, Henriquez W, Mehta B, Efthimiou P (2014) Effectiveness of combining tuberculin skin test and interferon gamma release assays as a screening strategy for detecting latent tuberculosis infection in high-risk patients with systemic lupus erythematosus. Ann Rheum Dis 72(Suppl 3):A478. https://doi.org/10.1136/annrheumdis-2013-eular.1435
Acharya B, Acharya A, Gautam S, Ghimire SP, Mishra G, Parajuli N, Sapkota B (2020) Advances in diagnosis of tuberculosis: an update into molecular diagnosis of Mycobacterium tuberculosis. Mol Biol Rep 47:4065–4075. https://doi.org/10.1007/s11033-020-05413-7
Hamada Y, Cirillo DM, Matteelli A, Penn-Nicholson A, Rangaka MX, Ruhwald M (2021) Tests for tuberculosis infection: landscape analysis. Eur Respir J 58:2100167. https://doi.org/10.1183/13993003.00167-2021
Furin J, Cox H, Pai M (2019) Tuberculosis. Lancet 393:1642–1656. https://doi.org/10.1016/S0140-6736(19)30308-3
Bello N, Birt JA, Workman J, Zhou X, Ross-Terres JA, Petri M (2022) Treatment patterns and clinical characteristics of patients with systemic lupus erythematosus and musculoskeletal symptoms: a retrospective, observational study. Adv Ther 39:3131–3145. https://doi.org/10.1007/s12325-022-02148-8
Al Balushi F, Al Salmi I, Metry AM, Yousef MA, Hannawi S (2018) Clinical pharmacological management status of systemic lupus erythematous population: situational analysis. J Rheum Dis Treat 4:068. https://doi.org/10.23937/2469-5726/1510068
Fragoulis GE, Nikiphorou E, Dey M, Zhao SS, Courvoisier DS, Arnaud L et al (2023) 2022 EULAR recommendations for screening and prophylaxis of chronic and opportunistic infections in adults with autoimmune inflammatory rheumatic diseases. Ann Rheum Dis 82:742–753. https://doi.org/10.1136/ard-2022-223335
Dörner T, Furie R (2019) Novel paradigms in systemic lupus erythematosus. Lancet 393:2344–2358. https://doi.org/10.1016/S0140-6736(19)30546-X
Al-Arbi KMS, Magula NP, Mody GM (2023) Tuberculosis remains a major burden in systemic lupus erythematosus patients in Durban, South Africa. Front Med (Lausanne) 10:1118390. https://doi.org/10.3389/fmed.2023.1118390
MacGregor-Fairlie M, Wilkinson S, Besra GS, Goldberg Oppenheimer P (2020) Tuberculosis diagnostics: overcoming ancient challenges with modern solutions. Emerg Top Life Sci 4:423–436. https://doi.org/10.1042/ETLS20200335
Iqbal H, Screws B, Khan MS (2023) A case of previously undiagnosed systemic lupus erythematosus and mycobacterium tuberculosis infection presenting as diffuse alveolar hemorrhage. Case Rep Rheumatol 2023:3686772. https://doi.org/10.1155/2023/3686772
Funding
The authors received no financial support for the research, authorship, and/or publication of this work.
Author information
Authors and Affiliations
Contributions
SS and BK analyzed and interpreted the patient’s data, performed the review of literature and drafted the manuscript, RK contributed to conception and design of the work, contributed to drafting the manuscript and revised it critically for important intellectual content, US and AB analyzed the patient’s data and contributed to drafting the manuscript. All authors read and approved the final version of the manuscript, and agreed to be accountable for all aspects of the work.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Informed consent
The participant has consented to the submission of the case report to the journal.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Smiyan, S., Koshak, B., Komorovsky, R. et al. Diagnostic challenge of tuberculosis in systemic lupus erythematosus: a case report and literature review. Rheumatol Int 43, 2131–2139 (2023). https://doi.org/10.1007/s00296-023-05400-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00296-023-05400-8